Peak step rates were lower in symptom-free mutation carriers
In a 28-day Fitbit study, 56 symptom-free people with a disease-linked gene expansion had lower peak step rates than 160 people without the mutation.In a 28-day Fitbit study, 56 symptom-free people with a disease-linked gene expansion had lower peak step rates than 160 people without the mutation.